Author: Aiden Fairbanks

February 7 2026 by Aiden Fairbanks

How Generics Cut Healthcare Drug Spending by 80-85% - The Real Cost-Saving Power

Generics make up 90% of U.S. prescriptions but only 12% of drug spending, saving over $445 billion in 2023 alone. Learn how they cut costs, why biosimilars lag, and what's blocking their full potential.

February 5 2026 by Aiden Fairbanks

How to Store Emergency Medications Securely Without Compromising Accessibility

Learn practical steps to store emergency medications safely while ensuring quick access during crises. From home use to medical facilities, discover temperature control tips, secure locking methods, and common mistakes to avoid. Proper storage prevents misuse and ensures drugs remain effective when needed most.

February 4 2026 by Aiden Fairbanks

Glaucoma Medications: Prostaglandins vs Beta Blockers for Safety and Effectiveness

Learn how prostaglandin eye drops and beta-blockers treat glaucoma. Compare their effectiveness, side effects, and safety profiles. Understand why doctors often choose one over the other. Find out about real-world patient experiences and current trends in glaucoma medication.

February 3 2026 by Aiden Fairbanks

Carbamazepine Generics: Enzyme Induction and Drug Interactions Explained

Carbamazepine generics can cause dangerous drops in drug levels due to enzyme induction and narrow therapeutic index. Learn why switching brands can trigger seizures, how to monitor levels, and which interactions are life-threatening.

February 2 2026 by Aiden Fairbanks

How to Prepare Unused Medications for Take-Back Events

Learn how to safely prepare unused medications for take-back events to prevent misuse and environmental harm. Follow simple steps to protect privacy, use correct containers, and avoid common mistakes.

February 1 2026 by Aiden Fairbanks

IgA Nephropathy: Prognosis and Current Therapies in 2026

IgA Nephropathy is the most common cause of primary kidney inflammation worldwide. New 2025 guidelines recommend combining targeted therapies like Nefecon with blood pressure control to slow progression. Learn the latest prognosis, treatment options, and real-world challenges.

January 29 2026 by Aiden Fairbanks

Import Inspections: How the FDA Monitors Drugs Entering the U.S.

The FDA uses a risk-based system to inspect drug shipments entering the U.S., blocking unsafe, counterfeit, or unapproved medications. With over 100 million entries annually, it inspects less than 1.2% physically-relying on data, alerts, and strict compliance rules.

January 28 2026 by Aiden Fairbanks

Alzheimer’s Disease: Understanding Memory Loss, Progression, and Current Treatments

Alzheimer’s disease causes progressive memory loss and cognitive decline. Learn how it progresses, what treatments work today - including the new FDA-approved drugs - and how lifestyle changes can help slow it down.

January 27 2026 by Aiden Fairbanks

Generic Drug Labeling Requirements: What the FDA Mandates

The FDA requires generic drug labels to match the brand-name version exactly-except for manufacturer details. This strict rule ensures consistency but creates dangerous delays in safety updates, affecting billions of prescriptions annually.

January 26 2026 by Aiden Fairbanks

Bone Health Screening: Understanding DEXA Scan Results and Fracture Risk

Learn how DEXA scan results like T-scores predict fracture risk and what to do if you have low bone density. Understand osteoporosis screening, FRAX risk tools, and when to seek treatment.